Acadian Asset Management LLC purchased a new stake in Blue Buffalo Pet Products Inc. (NASDAQ:BUFF) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 34,411 shares of the company’s stock, valued at approximately $803,000.

Several other hedge funds and other institutional investors have also made changes to their positions in BUFF. Apertura Capital LLC acquired a new position in shares of Blue Buffalo Pet Products during the first quarter valued at approximately $3,208,000. Barclays PLC raised its position in shares of Blue Buffalo Pet Products by 279.7% in the first quarter. Barclays PLC now owns 119,458 shares of the company’s stock valued at $2,987,000 after buying an additional 87,993 shares during the period. BlackRock Institutional Trust Company N.A. raised its position in shares of Blue Buffalo Pet Products by 7.7% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,095,026 shares of the company’s stock valued at $28,098,000 after buying an additional 78,581 shares during the period. A.R.T. Advisors LLC raised its position in shares of Blue Buffalo Pet Products by 323.5% in the first quarter. A.R.T. Advisors LLC now owns 66,635 shares of the company’s stock valued at $1,709,000 after buying an additional 50,900 shares during the period. Finally, BlackRock Group LTD raised its position in shares of Blue Buffalo Pet Products by 163.0% in the first quarter. BlackRock Group LTD now owns 75,848 shares of the company’s stock valued at $1,948,000 after buying an additional 47,005 shares during the period. Institutional investors own 90.05% of the company’s stock.

Shares of Blue Buffalo Pet Products Inc. (NASDAQ:BUFF) traded down 0.88% during mid-day trading on Friday, reaching $24.76. 1,488,951 shares of the company’s stock were exchanged. The stock has a market cap of $4.86 billion, a price-to-earnings ratio of 45.02 and a beta of 2.37. The stock’s 50-day moving average is $25.94 and its 200-day moving average is $24.80. Blue Buffalo Pet Products Inc. has a 52-week low of $15.19 and a 52-week high of $27.50.

Blue Buffalo Pet Products (NASDAQ:BUFF) last announced its quarterly earnings results on Wednesday, August 10th. The company reported $0.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.17 by $0.02. Blue Buffalo Pet Products had a net margin of 10.14% and a return on equity of 406.20%. The firm had revenue of $286.85 million for the quarter, compared to analyst estimates of $281.90 million. The company’s revenue was up 12.9% on a year-over-year basis. On average, equities analysts expect that Blue Buffalo Pet Products Inc. will post $0.76 EPS for the current year.

BUFF has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Blue Buffalo Pet Products from a “hold” rating to a “buy” rating and set a $27.00 price target on the stock in a research note on Wednesday, June 15th. Citigroup Inc. upped their price objective on shares of Blue Buffalo Pet Products from $30.00 to $31.00 and gave the stock a “buy” rating in a report on Thursday, August 11th. Oppenheimer Holdings Inc. began coverage on shares of Blue Buffalo Pet Products in a report on Thursday, September 8th. They set an “outperform” rating and a $30.00 price objective for the company. Wedbush reaffirmed a “neutral” rating and set a $25.00 price objective (up from $24.00) on shares of Blue Buffalo Pet Products in a report on Wednesday, August 10th. Finally, Stephens reaffirmed a “hold” rating on shares of Blue Buffalo Pet Products in a report on Thursday, June 30th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $28.86.

In other news, CEO Kurt Schmidt sold 150,000 shares of Blue Buffalo Pet Products stock in a transaction that occurred on Tuesday, July 5th. The shares were sold at an average price of $21.29, for a total value of $3,193,500.00. Following the sale, the chief executive officer now directly owns 203,571 shares in the company, valued at $4,334,026.59. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director L.P. Invus sold 15,014,548 shares of Blue Buffalo Pet Products stock in a transaction that occurred on Tuesday, July 5th. The shares were sold at an average price of $21.29, for a total transaction of $319,659,726.92. The disclosure for this sale can be found here. 10.30% of the stock is currently owned by company insiders.

Blue Buffalo Pet Products Company Profile

Blue Buffalo Pet Products, Inc (BBPP) is a holding company. The Company, through its subsidiaries, develops, produces, markets and sells pet food under the BLUE Life Protection Formula, BLUE Wilderness, BLUE Basics, BLUE Freedom and BLUE Natural Veterinary Diet lines. Blue Buffalo Company, Ltd. (Blue), Blue Buffalo Import Mexico, S.

5 Day Chart for NASDAQ:BUFF

Want to see what other hedge funds are holding BUFF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Blue Buffalo Pet Products Inc. (NASDAQ:BUFF).

Receive News & Ratings for Blue Buffalo Pet Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Buffalo Pet Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.